R13	Appositive Attribute:T109 Head:T52
R14	Anaphora Anaphor:T111 Antecedent:T4
R15	Anaphora Anaphor:T111 Antecedent:T72
R16	Anaphora Anaphor:T118 Antecedent:T72
R17	Anaphora Anaphor:T131 Antecedent:T2
R18	Anaphora Anaphor:T127 Antecedent:T131
R19	Anaphora Anaphor:T164 Antecedent:T162
R20	Anaphora Anaphor:T167 Antecedent:T164
R21	Cataphora Cataphor:T178 Consequent:T37
T1	Drug_Class 847 868	antihypertensive drug
T2	Drug 920 929	MINIPRESS
T7	Drug 1428 1437	MINIPRESS
T8	Drug_Class 1463 1475	beta-blocker
T9	Drug 1484 1495	propranolol
T10	Substance 3505 3512	alcohol
T14	Drug 2290 2299	MINIPRESS
T15	Substance 3634 3641	alcohol
T16	Drug 3595 3604	MINIPRESS
T18	Drug 4473 4482	MINIPRESS
T19	Drug_Class 4429 4437	diuretic
T20	Drug_Class 4447 4469	antihypertensive agent
T22	Drug_Class 4657 4679	antihypertensive drugs
T24	Drug 4584 4593	MINIPRESS
T25	Drug 4785 4794	MINIPRESS
T26	Drug_Class 4802 4839	phosphodiesterase-5 (PDE-5) inhibitor
T29	Drug 9286 9295	MINIPRESS
T30	Drug_Class 9303 9318	PDE-5 inhibitor
T34	Drug_Class 9414 9437	PDE-5 inhibitor therapy
T35	Drug 9496 9505	MINIPRESS
T36	Drug_Class 1290 1312	antihypertensive drugs
T37	Drug_Class 3944 3962	cardiac glycosides
T38	Drug_Class 7698 7716	hypotensive agents
T39	Drug_Class 9123 9145	antihypertensive agent
T40	Drug 3979 3986	digoxin
T41	Drug 4287 4296	quinidine
T42	Drug_Class 9105 9113	diuretic
T43	Drug 4008 4015	insulin
T44	Drug 4247 4258	propranolol
T45	Drug 3965 3974	digitalis
T46	Drug 5148 5162	norepinephrine
T47	Drug 4380 4392	indomethacin
T48	Drug 4371 4378	aspirin
T49	Drug 4140 4153	phenobarbital
T50	Drug_Class 7435 7447	beta-blocker
T51	Drug 0 9	MINIPRESS
T52	Drug 45 54	MINIPRESS
T53	Drug 186 195	MINIPRESS
T54	Drug 349 358	MINIPRESS
T55	Drug 1813 1822	MINIPRESS
T56	Drug 3812 3821	MINIPRESS
T57	Drug 4716 4725	MINIPRESS
T58	Drug 5746 5755	MINIPRESS
T59	Drug 5850 5859	MINIPRESS
T60	Drug 6255 6264	MINIPRESS
T61	Drug 6613 6622	MINIPRESS
T62	Drug 6755 6764	MINIPRESS
T63	Drug 6896 6905	MINIPRESS
T64	Drug 7938 7947	MINIPRESS
T65	Drug 7967 7976	MINIPRESS
T66	Drug 8111 8120	MINIPRESS
T67	Drug 8216 8225	MINIPRESS
T68	Drug 8386 8395	MINIPRESS
T69	Drug 9159 9168	MINIPRESS
T70	Drug 11 19	prazosin
T71	Drug 56 64	prazosin
T72	Drug 267 275	prazosin
T73	Drug 5046 5054	prazosin
T74	Drug 5333 5341	prazosin
T75	Drug 5372 5380	prazosin
T76	Drug 7420 7428	prazosin
T77	Drug 7586 7594	prazosin
T78	Drug 7635 7643	Prazosin
T79	Drug 7847 7855	prazosin
T80	Drug 4233 4245	procainamide
T81	Drug_Class 338 347	-blockers
T82	Drug_Class 4215 4230	antiarrhythmics
T83	Drug_Class 147 164	antihypertensives
T84	Drug 4183 4193	colchicine
T86	Drug_Class 4078 4105	tranquilizers and sedatives
T87	Drug 4017 4031	chlorpropamide
T88	Drug 4199 4209	probenecid
T89	Drug 4061 4072	tolbutamide
T4	Drug 253 265	quinazolines
T5	Substance 291 308	inert ingredients
T13	Drug_Class 2447 2463	alpha-1 blockers
T17	Drug_Class 2698 2713	mydriatic drugs
T21	Substance 2957 2980	viscoelastic substances
T23	Drug_Class 3032 3047	alpha-1 blocker
T32	Drug_Class 3992 4005	hypoglycemics
T33	Drug 4033 4043	phenformin
T90	Drug 4045 4055	tolazamide
T91	Drug 4108 4124	chlordiazepoxide
T92	Drug 4126 4134	diazepam
T93	Drug_Class 4159 4167	antigout
T85	Drug 4170 4181	allopurinol
T94	Drug_Class 4306 4316	analgesics
T95	Drug_Class 4318 4330	antipyretics
T96	Drug_Class 4335 4354	anti-inflammatories
T97	Drug 4357 4369	propoxyphene
T98	Drug 4398 4412	phenylbutazone
T242	SPAN 638 655	Syncopal episodes
T244	SPAN 8553 8564	three times
T107	ZeroArticleNP 35 42	capsule
T108	DefiniteNP 110 119	the first
T109	IndefiniteNP 81 105	a quinazoline derivative
T110	IndefiniteNP 123 143	a new chemical class
T111	DefiniteNP 287 308	the inert ingredients
T112	IndefiniteNP 329 347	all alpha-blockers
T113	DefiniteNP 521 541	the syncopal episode
T114	IndefiniteNP 457 497	an excessive postural hypotensive effect
T115	IndefiniteNP 563 569	a bout
T116	PersonalPronoun 749 753	they
T117	DefiniteNP 705 721	the initial dose
T118	DefiniteNP 725 733	the drug
T119	DefiniteNP 819 835	the introduction
T120	DefiniteNP 874 885	the regimen
T121	IndefiniteNP 839 868	another antihypertensive drug
T122	IndefiniteNP 889 898	a patient
T123	DefiniteNP 931 944	The incidence
T124	IndefiniteNP 1004 1019	an initial dose
T125	DefiniteNP 1073 1098	the investigational phase
T126	DefiniteNP 1172 1188	the initial dose
T127	DefiniteNP 1192 1200	the drug
T128	DefiniteNP 1237 1247	the dosage
T129	DefiniteNP 1318 1329	the patient
T130	IndefiniteNP 1275 1312	any additional antihypertensive drugs
T131	DemonstrativeNP 1102 1111	this drug
T132	IndefiniteNP 1461 1475	a beta-blocker
T133	DefiniteNP 1517 1528	the patient
T134	DefiniteNP 1549 1571	the recumbent position
T135	DefiniteNP 1687 1705	the initial period
T136	DemonstrativeNP 1611 1630	This adverse effect
T137	ZeroArticleNP 1709 1716	therapy
T138	DefiniteNP 1792 1809	the 1 mg capsules
T139	DefiniteNP 1824 1847	The 2 and 5 mg capsules
T140	ZeroArticleNP 1870 1885	initial therapy
T141	DefiniteNP 1931 1943	the symptoms
T142	DefiniteNP 1978 1996	the blood pressure
T143	PersonalPronoun 2147 2151	they
T144	DefiniteNP 2037 2048	The patient
T145	DemonstrativeNP 2075 2105	these possible adverse effects
T146	DefiniteNP 2161 2172	The patient
T147	DefiniteNP 2272 2286	the initiation
T148	ZeroArticleNP 2290 2307	MINIPRESS therapy
T149	IndefiniteNP 2420 2433	some patients
T150	ZeroArticleNP 2447 2463	alpha-1 blockers
T151	DefiniteNP 2522 2537	the combination
T152	DefiniteNP 2741 2749	the iris
T153	DefiniteNP 2757 2790	the phacoemulsification incisions
T154	IndefiniteNP 2541 2555	a flaccid iris
T155	DemonstrativeNP 2465 2477	This variant
T156	ZeroArticleNP 2689 2713	standard mydriatic drugs
T157	DefiniteNP 2792 2803	The patient
T158	DefiniteNP 2871 2893	the surgical technique
T159	DefiniteNP 2903 2918	the utilization
T160	ZeroArticleNP 2957 2980	viscoelastic substances
T161	IndefiniteNP 3010 3019	a benefit
T162	ZeroArticleNP 3032 3055	alpha-1 blocker therapy
T163	DefiniteNP 3150 3164	the first dose
T164	DemonstrativeNP 3168 3181	this medicine
T165	DefiniteNP 3231 3249	the first 24 hours
T166	DefiniteNP 3285 3293	the dose
T167	DemonstrativeNP 3263 3276	this medicine
T168	IndefiniteNP 3387 3414	a lying or sitting position
T169	DefiniteNP 3450 3461	the problem
T170	PersonalPronoun 3495 3498	you
T171	DefiniteNP 3562 3573	the weather
T172	DemonstrativeNP 3463 3476	These effects
T173	PersonalPronoun 3642 3645	you
T174	DefiniteNP 3620 3630	the amount
T175	PersonalPronoun 3768 3771	you
T176	PossessivePronoun 3750 3764	your physician
T177	IndefiniteNP 3777 3790	any questions
T178	DefiniteNP 3925 3938	the following
T179	IndefiniteNP 3852 3880	any adverse drug interaction
T180	ZeroArticleNP 4078 4105	tranquilizers and sedatives
T181	ZeroArticleNP 4159 4167	antigout
T182	ZeroArticleNP 4215 4230	antiarrhythmics
T183	IndefiniteNP 4427 4469	a diuretic or other antihypertensive agent
T184	IndefiniteNP 4507 4537	an additive hypotensive effect
T185	DefiniteNP 4580 4598	the MINIPRESS dose
T186	IndefiniteNP 4624 4629	a day
T187	DemonstrativeNP 4539 4550	This effect
T188	ZeroArticleNP 4646 4679	additional antihypertensive drugs
T189	IndefiniteNP 4800 4839	a phosphodiesterase-5 (PDE-5) inhibitor
T190	DefiniteNP 5122 5144	the urinary metabolite
T191	IndefiniteNP 4995 5002	a study
T192	IndefiniteNP 5092 5111	an average increase
T193	IndefiniteNP 5167 5186	an average increase
T194	DefiniteNP 5408 5419	the patient
T195	IndefiniteNP 5346 5361	an elevated VMA
T196	IndefiniteNP 5435 5442	a month
T197	DefiniteNP 5791 5808	the usual maximum
T198	IndefiniteNP 5715 5732	an 18 month study
T199	DefiniteNP 6041 6058	the usual maximum
T200	DefiniteNP 6162 6179	the usual maximum
T201	IndefiniteNP 5920 5931	a fertility
T202	DefiniteNP 6372 6389	the usual maximum
T203	DefiniteNP 6489 6506	the usual maximum
T204	DefiniteNP 6543 6565	the testicular changes
T205	IndefiniteNP 6701 6714	a drug effect
T206	ZeroArticleNP 6603 6630	long term MINIPRESS therapy
T207	ZeroArticleNP 6840 6851	drug effect
T208	DefiniteNP 7045 7062	the usual maximum
T209	DefiniteNP 7352 7369	the usual maximum
T210	DefiniteNP 7409 7416	The use
T211	DefiniteNP 7452 7463	the control
T212	IndefiniteNP 7433 7447	a beta-blocker
T213	ZeroArticleNP 7573 7580	Therapy
T214	IndefiniteNP 7692 7716	other hypotensive agents
T215	IndefiniteNP 7756 7775	other investigators
T216	ZeroArticleNP 7675 7686	combination
T217	DefiniteNP 7836 7843	the use
T218	DefiniteNP 7924 7934	the safety
T219	DefiniteNP 8017 8038	the potential benefit
T220	DefiniteNP 8049 8067	the potential risk
T221	DefiniteNP 8071 8081	the mother
T222	IndefiniteNP 8245 8260	a nursing woman
T223	DefiniteNP 8374 8382	The dose
T224	DefiniteNP 8428 8439	the patient
T225	PossessivePronoun 8506 8524	its administration
T226	DefiniteNP 8478 8491	The following
T227	IndefiniteNP 8495 8502	a guide
T228	IndefiniteNP 8565 8570	a day
T229	IndefiniteNP 8640 8658	a total daily dose
T230	DefiniteNP 8692 8715	The therapeutic dosages
T231	IndefiniteNP 8866 8880	a few patients
T232	IndefiniteNP 8922 8934	a daily dose
T233	IndefiniteNP 8992 9005	some patients
T234	IndefiniteNP 9038 9066	a twice daily dosage regimen
T235	IndefiniteNP 9078 9089	Other Drugs
T236	DefiniteNP 9147 9155	the dose
T237	IndefiniteNP 9103 9145	a diuretic or other antihypertensive agent
T238	IndefiniteNP 9215 9220	a day
T239	DefiniteNP 9461 9476	the lowest dose
T240	IndefiniteNP 9301 9318	a PDE-5 inhibitor
T241	ZeroArticleNP 9414 9437	PDE-5 inhibitor therapy
